BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 17245717)

  • 21. [Hepatitis B virus gene mutations in the sera of three patients with coexisting hepatitis B surface antigen and anti-surface antibody].
    Yukimasa N; Ohkushi H; Fukasawa K; Fukuchi K; Takagi Y; Gomi K
    Rinsho Byori; 2000 Feb; 48(2):184-8. PubMed ID: 10804824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Quasi species of the pre-S/S gene and mutations of enhancer II/core promoter/pre-C in mothers and their children infected with hepatitis B virus via mother-to-infant transmission.
    Xu H; Peng M; Qing Y; Ling N; Lan Y; Liang Z; Cai D; Li Y; Ren H
    J Infect Dis; 2006 Jan; 193(1):88-97. PubMed ID: 16323136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of hepatitis B virus replication by expression of polymerase-surface fusion protein through splicing: implications for viral persistence.
    Park GS; Kim HY; Shin HS; Park S; Shin HJ; Kim K
    Virus Res; 2008 Sep; 136(1-2):166-74. PubMed ID: 18562032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan.
    Mu SC; Lin YM; Jow GM; Chen BF
    J Hepatol; 2009 Feb; 50(2):264-72. PubMed ID: 19070923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-type dependent expression and secretion of hepatitis B virus pre-S1 surface antigen.
    Marquardt O; Heermann KH; Seifer M; Gerlich WH
    Postgrad Med J; 1987; 63 Suppl 2():41-50. PubMed ID: 3317359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection.
    Fan YF; Lu CC; Chen WC; Yao WJ; Wang HC; Chang TT; Lei HY; Shiau AL; Su IJ
    Hepatology; 2001 Jan; 33(1):277-86. PubMed ID: 11124846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pre-S region determines the intracellular localization and appearance of hepatitis B virus.
    Bock CT; Tillmann HL; Manns MP; Trautwein C
    Hepatology; 1999 Aug; 30(2):517-25. PubMed ID: 10421662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An HBV large surface antigen protein which can be secreted from mammalian cells.
    Yu XM; Wang Y; Li ZP
    Sci China B; 1992 Apr; 35(4):455-62. PubMed ID: 1590920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutant.
    Lai MW; Yeh CT
    Antivir Ther; 2008; 13(7):875-9. PubMed ID: 19043921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Down-regulating effect of hepatitis B virus pre-S2 protein upon insulin receptor gene promoter].
    Ji D; Han P; Zhang J; Shao Q; Liu Y; Wang L; Chen GF
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(43):3069-73. PubMed ID: 20137637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication.
    Nakatake H; Chisaka O; Yamamoto S; Matsubara K; Koshy R
    Virology; 1993 Aug; 195(2):305-14. PubMed ID: 8337816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
    Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
    Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
    Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
    Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrahepatic expression of pre-S proteins of hepatitis B virus and its possible relation to liver cell necrosis.
    Hu KQ; Hao LJ; Zhang YY; Wang YK
    Am J Gastroenterol; 1989 Dec; 84(12):1538-42. PubMed ID: 2596456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.
    Gripon P; Le Seyec J; Rumin S; Guguen-Guillouzo C
    Virology; 1995 Nov; 213(2):292-9. PubMed ID: 7491754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis.
    Märschenz S; Endres AS; Brinckmann A; Heise T; Kristiansen G; Nürnberg P; Krüger DH; Günther S; Meisel H
    Gastroenterology; 2006 Sep; 131(3):765-80. PubMed ID: 16952546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential pattern of pre-S mutations/deletions and its association with hepatitis B virus genotypes in Eastern India.
    Biswas A; Panigrahi R; Banerjee A; Pal M; De BK; Chakrabarti S; Chakravarty R
    Infect Genet Evol; 2012 Mar; 12(2):384-91. PubMed ID: 22266243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.